Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Nov 10, 2015Transaction to Expand Boston Scientific Interventional Oncology Portfolio with Drug-Eluting Microspheres and Spherical EmbolicsTransaction to expand interventional oncology portfolio with drug-eluting microspheres and spherical embolics
- Oct 28, 2015
"Our excellent third quarter performance was driven by strong sales and differentiated adjusted operating margin expansion," said CEO Mike Mahoney
Oct 8, 2015Investment continues alliance for percutaneous mitral valve replacement established in 2012Investment continues alliance for percutaneous mitral valve replacement established in 2012
- Oct 7, 2015Up to $25,000 in Prizes to be Awarded to Winners
Up to $25,000 in prizes to be awarded to winners
- Oct 5, 2015Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent SystemNew Category of Drug-Eluting Stent Approved For U.S. Patients
New category of drug-eluting stent approved for U.S. patients
Sep 29, 2015Provides minimally invasive alternative to an esophagectomy
Sep 28, 2015MAJESTIC Trial Data Support Strong Safety Profile with Low Target Lesion Revascularization RateMAJESTIC trial data support strong safety profile with low target lesion revascularization rate
Sep 10, 2015System Includes First Directional Lead with Current Steering and Expanded Programming FlexibilitySystem includes first directional lead with current steering and expanded programming flexibility
Aug 24, 2015Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systemsUpdated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems
Aug 19, 2015U.S. Launch Underway for Therapy Designed to Treat Peripheral Artery DiseaseU.S. launch underway for therapy designed to treat Peripheral Artery Disease
